A new market study, titled “Global Transdermal Drug Delivery System Market Size, Status and Forecast 2025”, has been featured on WiseGuyReports.
This report studies the global Transdermal Drug Delivery System market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Transdermal Drug Delivery System market by companies, region, type and end-use industry.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 is about 31.1%. Transdermal Drug Delivery System can be used for OTC, Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion is about 83.3% in 2016.
North America is the largest sales place, with a revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place with the revenue market share of 28%. China and Japan are also important sales regions for Transdermal Drug Delivery System.
The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.
Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2017, the global Transdermal Drug Delivery System market size was 8950 million US$ and it is expected to reach 24300 million US$ by the end of 2025, with a CAGR of 13.3% during 2018-2025.
Request Sample Report at https://www.wiseguyreports.com/sample-request/3243529-global-transdermal-drug-delivery-system-market-size-status-and-forecast-2025
This report focuses on the global top players, covered
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Market segment by Application, split into
OTC
Rx
The study objectives of this report are:
To study and forecast the market size of Transdermal Drug Delivery System in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Transdermal Drug Delivery System are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Transdermal Drug Delivery System Manufacturers
Transdermal Drug Delivery System Distributors/Traders/Wholesalers
Transdermal Drug Delivery System Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
1 Industry Overview of Transdermal Drug Delivery System
2 Global Transdermal Drug Delivery System Competition Analysis by Players
3 Company (Top Players) Profiles
4 Global Transdermal Drug Delivery System Market Size by Type and Application (2013-2018)
5 United States Transdermal Drug Delivery System Development Status and Outlook
6 Europe Transdermal Drug Delivery System Development Status and Outlook
7 China Transdermal Drug Delivery System Development Status and Outlook
8 Japan Transdermal Drug Delivery System Development Status and Outlook
9 Southeast Asia Transdermal Drug Delivery System Development Status and Outlook
10 India Transdermal Drug Delivery System Development Status and Outlook
11 Market Forecast by Regions, Type and Application (2018-2025)
12 Transdermal Drug Delivery System Market Dynamics
13 Market Effect Factors Analysis
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
